Sfoglia per Rivista
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo
2009-01-01 Di Martino, Mt; Ventura, M; Pietragalla, A; Cucinotto, I; Calimeri, T; Bulotta, A; Neri, P; Caraglia, M; Tagliaferri, P; Tassone, P
pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: A tissue-microarray study with clinic-pathological correlations.
2012-01-01 Aquino, G; Pannone, G; Santoro, A; Liguori, G; Franco, R; Serpico, R; Florio, G; De Rosa, A; Mattoni, M; Cozza, V; Botti, G; Losito, S; Longo, F; Staibano, S; Cuda, G; Lo Muzio, L; Sbordone, C; Bufo, P; Grimaldi, A; Caraglia, M; Di Domenico, M.
Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials
2014-01-01 Staropoli, N; Ciliberto, D; Botta, C; Fiorillo, L; Grimaldi, A; Lama, S; Caraglia, M; Salvino, A; Tagliaferri, P; Tassone, P
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
2011-01-01 Correale, P; Botta, C; Basile, A; Pagliuchi, M; Licchetta, A; Martellucci, I; Bestoso, E; Apollinari, S; Addeo, R; Misso, G; Romano, O; Abbruzzese, A; Lamberti, M; Luzzi, L; Gotti, G; Rotundo, Ms; Caraglia, M; Tagliaferri, P
Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine
2009-01-01 Correale, P; Miano, St; Remondo, C; Migali, C; Rotundo, Ms; Macrì, P; Tagliaferri, P; Tassone, P; Caraglia, M; Gotti, G; Francini, G
Second-line treatment of non-small cell lung cancer by biweekly gemcitabine and docetaxel plus /- granulocyte-macrophage colony stimulating factor and low dose aldesleukine
2009-01-01 Correale, P; Miano, St; Remondo, C; Migali, C; Rotundo, Ms; Macri, P; Tagliaferri, P; Tassone, P; Caraglia, M; Gotti, G; Francini, G
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study
2011-01-01 Di Martino Maria, Teresa; Arbitrio, Mariamena; Leone, Emanuela; Rotundo Maria, Saveria; Ciliberto, Domenico; Tomaino, Vera; Fabiani, Fernanda; Talarico, Danilo; Sperlongano, Pasquale; Cannataro, Mario; Caraglia, Michele; Tagliaferri, P; Cannataro, M; Tassone, P; Doldo, P; Guzzi, P
Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro
2014-01-01 Marvaso, G; Barone, A; Amodio, N; Raimondi, L; Altomare, E; Scotti, V; Lombardi, A; Bianco, R; Caraglia, M; Tassone, P; Tagliaferri, P; Agosti, V; Bianco, C
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients.
2013-01-01 Botta, Cirino; Barbieri, Vito; Ciliberto, Domenico; Rossi, Antonio; Rocco, Danilo; Addeo, Raffaele; Staropoli, Nicoletta; Pastina, Pierpaolo; Marvaso, Giulia; Martellucci, Ignazio; Guglielmo, Annamaria; Pirtoli, Luigi; Sperlongano, Pasquale; Gridelli, Cesare; Caraglia, Michele; Tassone, P; Correale, Pierpaolo; Tagliaferri, P
The role of G-CSF in the treatment of advanced tumors
2009-01-01 Bottoni, U; Trapasso, F
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse
2016-01-01 Nardone, V; Botta, C; Caraglia, M; Martino, Ec; Ambrosio, Mr; Carfagno, T; Tini, P; Semeraro, L; Misso, G; Grimaldi, A; Boccellino, M; Facchini, G; Berretta, M; Vischi, G; Rocca, Bj; Barone, A; Tassone, P; Tagliaferri, P; Del Vecchio, Mt; Pirtoli, L; Correale, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo | 1-gen-2009 | Di Martino, Mt; Ventura, M; Pietragalla, A; Cucinotto, I; Calimeri, T; Bulotta, A; Neri, P; Caraglia, M; Tagliaferri, P; Tassone, P | |
pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: A tissue-microarray study with clinic-pathological correlations. | 1-gen-2012 | Aquino, G; Pannone, G; Santoro, A; Liguori, G; Franco, R; Serpico, R; Florio, G; De Rosa, A; Mattoni, M; Cozza, V; Botti, G; Losito, S; Longo, F; Staibano, S; Cuda, G; Lo Muzio, L; Sbordone, C; Bufo, P; Grimaldi, A; Caraglia, M; Di Domenico, M. | |
Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials | 1-gen-2014 | Staropoli, N; Ciliberto, D; Botta, C; Fiorillo, L; Grimaldi, A; Lama, S; Caraglia, M; Salvino, A; Tagliaferri, P; Tassone, P | |
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients | 1-gen-2011 | Correale, P; Botta, C; Basile, A; Pagliuchi, M; Licchetta, A; Martellucci, I; Bestoso, E; Apollinari, S; Addeo, R; Misso, G; Romano, O; Abbruzzese, A; Lamberti, M; Luzzi, L; Gotti, G; Rotundo, Ms; Caraglia, M; Tagliaferri, P | |
Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine | 1-gen-2009 | Correale, P; Miano, St; Remondo, C; Migali, C; Rotundo, Ms; Macrì, P; Tagliaferri, P; Tassone, P; Caraglia, M; Gotti, G; Francini, G | |
Second-line treatment of non-small cell lung cancer by biweekly gemcitabine and docetaxel plus /- granulocyte-macrophage colony stimulating factor and low dose aldesleukine | 1-gen-2009 | Correale, P; Miano, St; Remondo, C; Migali, C; Rotundo, Ms; Macri, P; Tagliaferri, P; Tassone, P; Caraglia, M; Gotti, G; Francini, G | |
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study | 1-gen-2011 | Di Martino Maria, Teresa; Arbitrio, Mariamena; Leone, Emanuela; Rotundo Maria, Saveria; Ciliberto, Domenico; Tomaino, Vera; Fabiani, Fernanda; Talarico, Danilo; Sperlongano, Pasquale; Cannataro, Mario; Caraglia, Michele; Tagliaferri, P; Cannataro, M; Tassone, P; Doldo, P; Guzzi, P | |
Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro | 1-gen-2014 | Marvaso, G; Barone, A; Amodio, N; Raimondi, L; Altomare, E; Scotti, V; Lombardi, A; Bianco, R; Caraglia, M; Tassone, P; Tagliaferri, P; Agosti, V; Bianco, C | |
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients. | 1-gen-2013 | Botta, Cirino; Barbieri, Vito; Ciliberto, Domenico; Rossi, Antonio; Rocco, Danilo; Addeo, Raffaele; Staropoli, Nicoletta; Pastina, Pierpaolo; Marvaso, Giulia; Martellucci, Ignazio; Guglielmo, Annamaria; Pirtoli, Luigi; Sperlongano, Pasquale; Gridelli, Cesare; Caraglia, Michele; Tassone, P; Correale, Pierpaolo; Tagliaferri, P | |
The role of G-CSF in the treatment of advanced tumors | 1-gen-2009 | Bottoni, U; Trapasso, F | |
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse | 1-gen-2016 | Nardone, V; Botta, C; Caraglia, M; Martino, Ec; Ambrosio, Mr; Carfagno, T; Tini, P; Semeraro, L; Misso, G; Grimaldi, A; Boccellino, M; Facchini, G; Berretta, M; Vischi, G; Rocca, Bj; Barone, A; Tassone, P; Tagliaferri, P; Del Vecchio, Mt; Pirtoli, L; Correale, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile